Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,806 | -13,963 | -28,720 | -16,722 | -28,001 |
| Depreciation Amortization | 1,190 | 587 | 2,266 | 1,672 | 1,116 |
| Accounts receivable | 465 | 215 | N/A | -1,612 | -1,692 |
| Accounts payable and accrued liabilities | -103 | 851 | N/A | 1,514 | -72 |
| Other Working Capital | -3,023 | -3,016 | -28,280 | -27,193 | -3,398 |
| Other Operating Activity | 4,506 | 240 | 7,304 | 5,586 | 6,040 |
| Operating Cash Flow | $-28,771 | $-15,086 | $-47,430 | $-36,755 | $-26,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,613 | 9,800 | N/A | -20,685 | -20,371 |
| PPE Investments | -482 | -18 | -3,258 | -2,622 | -2,443 |
| Other Investing Activity | 0 | 0 | -22,717 | 0 | 0 |
| Investing Cash Flow | $11,131 | $9,782 | $-25,975 | $-23,307 | $-22,814 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 23,431 | N/A |
| Debt Repayment | -78 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 22 | N/A | N/A | 10 | 10 |
| Common Stock Repurchased | N/A | N/A | N/A | -12 | -12 |
| Other Financing Activity | -1,560 | 0 | 24,391 | 0 | 0 |
| Financing Cash Flow | $-1,616 | $N/A | $24,391 | $23,429 | $-2 |
| Beginning Cash Position | 53,762 | 53,762 | 102,776 | 102,776 | 102,776 |
| End Cash Position | 34,506 | 48,458 | 53,762 | 66,143 | 53,953 |
| Net Cash Flow | $-19,256 | $-5,304 | $-49,014 | $-36,633 | $-48,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,771 | -15,086 | -47,430 | -36,755 | -26,007 |
| Capital Expenditure | -482 | -18 | N/A | -2,622 | -2,443 |
| Free Cash Flow | -29,253 | -15,104 | -47,430 | -39,377 | -28,450 |